Quarterly ResultMay 14, 2026, 04:28 PM
AVITA Medical Q1 Net Loss $(10.6)M; Going Concern Doubt Raised
AI Summary
AVITA Medical, Inc. reported its first-quarter 2026 financial results, showing a net loss of $(10.6) million and total revenues of $19.3 million. Despite an improvement in net loss and operating loss compared to the prior year, management expressed substantial doubt about the company's ability to continue as a going concern over the next twelve months due to recurring losses and debt obligations. The company recently secured a new $60.0 million credit facility, which included refinancing previous debt and lowering its minimum cash balance covenant.
Key Highlights
- AVITA Medical reported a net loss of $(10.6) million for Q1 2026, an improvement from $(13.9) million in Q1 2025.
- Total revenues increased to $19.3 million in Q1 2026 from $18.5 million in Q1 2025.
- Operating loss improved to $(8.8) million in Q1 2026 from $(11.8) million in Q1 2025.
- Basic and diluted net loss per common share was $(0.35) in Q1 2026, compared to $(0.53) in Q1 2025.
- The company used $(10.1) million in cash from operating activities in Q1 2026.
- AVITA Medical secured a new $60.0 million senior secured credit facility, with $50.0 million funded at issuance.
- The company's minimum cash balance covenant was lowered to $5.0 million under the new credit agreement.
- Accumulated deficit reached $(419.0) million as of March 31, 2026.